| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/07/2011 | US20110166104 Boron-containing small molecules |
| 07/07/2011 | US20110166103 Boron-containing small molecules |
| 07/07/2011 | US20110166102 Novel 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
| 07/07/2011 | US20110166101 Microparticles |
| 07/07/2011 | US20110166100 Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease |
| 07/07/2011 | US20110166099 Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer |
| 07/07/2011 | US20110166098 Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease |
| 07/07/2011 | US20110166097 Taxane compounds for treating eye disease |
| 07/07/2011 | US20110166096 Uracil derivatives and use thereof |
| 07/07/2011 | US20110166095 Cancer platinum resistance detection and sensitization method |
| 07/07/2011 | US20110166094 Agonists of a2a adenosine receptors for treating recurrent tumor growth |
| 07/07/2011 | US20110166093 Use of adenosine receptor agonists in therapy |
| 07/07/2011 | US20110166092 Dosing methods for treating disease |
| 07/07/2011 | US20110166091 Compositions Containing Piperacillin and Tazobactam Useful for Injection |
| 07/07/2011 | US20110166090 18-Membered Macrocycles and Analogs Thereof |
| 07/07/2011 | US20110166089 Solution for tissue adhesion prevention and method for tissue adhesion prevention |
| 07/07/2011 | US20110166088 Benzothiazoles and aza-analogues thereof use as antibacterial agents |
| 07/07/2011 | US20110166087 Pharmaceutical composition for use in treating sexually transmitted infections |
| 07/07/2011 | US20110166086 Flavor improving agent |
| 07/07/2011 | US20110166082 Antisense composition and method for treating muscle atrophy |
| 07/07/2011 | US20110166078 Oligosaccharide compounds for use in mobilising stem cells |
| 07/07/2011 | US20110166077 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 07/07/2011 | US20110166074 Cln2 treatment of alzheimer's disease |
| 07/07/2011 | US20110166065 Modulation of glucose-6-phosphatase translocase expression |
| 07/07/2011 | US20110166060 Tympanic membrane permeating ear drops and uses thereof |
| 07/07/2011 | US20110166058 Organic compositions to treat hsf1-related diseases |
| 07/07/2011 | US20110165653 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 07/07/2011 | US20110165633 Production of Polyketides and Other Natural Products |
| 07/07/2011 | US20110165277 Biological Materials and Uses Thereof |
| 07/07/2011 | US20110165272 Antiallergic composition |
| 07/07/2011 | US20110165266 Screen for inhibitors of hiv replication |
| 07/07/2011 | US20110165264 Use of cilastatin to reduce nephrotatoxicity of various compounds |
| 07/07/2011 | US20110165262 Reducing drug dependence or addiction |
| 07/07/2011 | US20110165261 Antimicrobial compositions and methods of use |
| 07/07/2011 | US20110165260 Allantoin-containing skin cream |
| 07/07/2011 | US20110165259 Composite organic compound powder for medical use, method for producing same and suspension of same |
| 07/07/2011 | US20110165258 Polymeric delivery systems for active agents |
| 07/07/2011 | US20110165257 Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea |
| 07/07/2011 | US20110165256 Compositions and methods for treatment of hyperplasia |
| 07/07/2011 | US20110165254 Drug Delivery Using Fine Fiber Encapsulation |
| 07/07/2011 | US20110165253 Nicotine-containing granulate |
| 07/07/2011 | US20110165252 Memantine formulations |
| 07/07/2011 | US20110165251 Liquid dosage compositions of stable nanoparticulate active agents |
| 07/07/2011 | US20110165249 Pharmaceutical solid preparation |
| 07/07/2011 | US20110165248 Pharmaceutical dosage forms comprising poly(e-caprolactone) |
| 07/07/2011 | US20110165247 Device for the transdermal administration of a rotigotine base |
| 07/07/2011 | US20110165242 In situ gelling drug delivery system |
| 07/07/2011 | US20110165241 Bazedoxifene formulations with antioxidants |
| 07/07/2011 | US20110165240 Galenical formulations of organic compounds |
| 07/07/2011 | US20110165239 Pharmaceutical compositions of atorvastatin |
| 07/07/2011 | US20110165238 Stabilized atypical antipsychotic formulation |
| 07/07/2011 | US20110165237 Protein Hydrolysate Excipients |
| 07/07/2011 | US20110165236 Controlled release hydrogel formulation |
| 07/07/2011 | US20110165235 Directly pressed aliskiren tablets |
| 07/07/2011 | US20110165234 Extended release venlafaxine formulation |
| 07/07/2011 | US20110165232 Use of Opioid Antagonists for the Preparation of a Medicament in the Treatment of Retinal Degenerative Diseases |
| 07/07/2011 | US20110165229 Compositions and Methods for Treatment |
| 07/07/2011 | US20110165228 Compositions and Methods for Treatment |
| 07/07/2011 | US20110165227 Compositions and Methods Using siRNA Molecules for Treatment of Gliomas |
| 07/07/2011 | US20110165226 Influenza cap-leader sequence |
| 07/07/2011 | US20110165225 Modified Drugs for Use in Liposomal Nanoparticles |
| 07/07/2011 | US20110165222 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 07/07/2011 | US20110165220 Drugs to prevent hpv infection |
| 07/07/2011 | US20110165218 Therapeutic Bone Growth and Regeneration |
| 07/07/2011 | US20110165216 Hydrogen Sulfide Generating Polymers |
| 07/07/2011 | US20110165204 Gastric therapies and compositions therefor |
| 07/07/2011 | US20110165203 A topical composition comprising the isolated non-polar lipid fraction of lanolin4 |
| 07/07/2011 | US20110165202 Solid state forms of fosamprenavir calcium salt and processes for preparation thereof |
| 07/07/2011 | US20110165201 Anticancer formulation |
| 07/07/2011 | US20110165198 Method for reducing lipid absorption by an animal |
| 07/07/2011 | US20110165188 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 07/07/2011 | US20110165186 Novel pyridine alkaloids, preparation process thereof, and the uses of the pyridine alkaloids |
| 07/07/2011 | US20110165183 Piperidine derivatives as jak3 inhibitors |
| 07/07/2011 | US20110165178 Diagnosis of prostate cancer |
| 07/07/2011 | US20110165176 Aldosterone induced vascular elastin production |
| 07/07/2011 | US20110165166 Lsr receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
| 07/07/2011 | US20110165148 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 07/07/2011 | US20110165147 Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor |
| 07/07/2011 | US20110165144 Methods for treating rheumatoid arthritis |
| 07/07/2011 | US20110165141 Compositions for treating bacterial infections |
| 07/07/2011 | US20110165137 Suppression of cancers |
| 07/07/2011 | US20110165125 Methods for enhancing energy metabolism |
| 07/07/2011 | US20110165123 5' triphosphate oligonucleotide with blunt end and uses thereof |
| 07/07/2011 | US20110165120 Inhibitors of serine proteases |
| 07/07/2011 | US20110165118 3-heterocyclic substituted indole derivatives and methods of use thereof |
| 07/07/2011 | US20110165117 Immunogenic peptides and methods of use |
| 07/07/2011 | US20110165100 Compositions comprising avermectin/azelaic acid compounds useful for treating, e.g., rosacea |
| 07/07/2011 | US20110165098 Methods to prevent cytotoxicity using n-acetyl-cysteine |
| 07/07/2011 | US20110165097 Compositions for percutaneous administration |
| 07/07/2011 | US20110165093 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission |
| 07/07/2011 | US20110165092 Cosmetic and/or dermatological composition |
| 07/07/2011 | US20110165079 Peptide for transmigration across blood brain barrier and delivery systems comprising the same |
| 07/07/2011 | US20110165073 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 07/07/2011 | US20110165068 Liposome medicament, method of preparation and use thereof |
| 07/07/2011 | US20110165067 Carbohydrate functionalized catanionic surfactant vesicles for drug delivery |
| 07/07/2011 | US20110165065 Means for the detection and treatment of prostate cells |
| 07/07/2011 | DE102009028929A1 Heterocyclisch-substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and their use |
| 07/07/2011 | CA2822435A1 Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
| 07/07/2011 | CA2788450A1 Substituted naphthalenyl-pyrimidine compounds |
| 07/07/2011 | CA2786282A1 Balloon catheter systems for delivery of dry drug delivery vesicles to a vessel in the body |